
Rewiring ERBB3 and ERK signaling confers resistance to FGFR1 inhibition in gastrointestinal cancer harbored an ERBB3-E928G mutation
{{custom_author.name}}, {{article.zuoZheEn}}
Rewiring ERBB3 and ERK signaling confers resistance to FGFR1 inhibition in gastrointestinal cancer harbored an ERBB3-E928G mutation
[{{custom_ref.label}}] |
{{custom_citation.content}}
|
/
〈 |
|
〉 |